Sort   by:  
 Page size 
UnknownChromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma.
Not available
S-EPMC5141358 | biostudies-literature
UnknownSoluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma.
Not available
S-EPMC10506048 | biostudies-literature
ProteomicsADAR1-mediated RNA editing promotes B cell lymphomagenesis.
The project aims to evaluate the contribution of ADAR1 RNA editing to B cell lymphomagenesis, specifically in diffuse large B cell lymphoma (DLBCL). Within our DLBCL cohort, RNA editing targets transcripts within known lymphoma-driving pathways such as apoptosis, p53 and NF-kB signaling, as well as ...
ORGANISM(S): Homo sapiens (Human) 
2023-07-20 | PXD041549 | Pride
Adar1 Mavs Rck8 Dlbcl 
UnknownCell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.
Not available
S-EPMC6916573 | biostudies-literature
UnknownTriggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy.
Not available
S-EPMC7820876 | biostudies-literature
UnknownTumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma.
Not available
S-EPMC12490240 | biostudies-literature
UnknownTumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma.
Not available
S-EPMC10313378 | biostudies-literature
UnknownADAR1-mediated RNA editing promotes B cell lymphomagenesis.
Not available
S-EPMC10225930 | biostudies-literature
UnknownRepurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327 | biostudies-literature
UnknownHealth in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Not available
S-EPMC6660972 | biostudies-literature
Sort   by:  
 Page size